As shown in Figure 5, AMH levels, pooled from 7 studies including 1,507 participants, was not significantly different between BRCA and non-BRCA BC patients (MD: 0.14, 95% CI: -0.71 to 0.99), p=0.75 (I2 = 68%). The gene discussed is AMH; the disease is breast cancer.